Life Sciences

Mintz’s team of industry-dedicated attorneys helps entrepreneurs launch and protect great ideas, facilitates funding opportunities, works with leading industry investors and underwriters in innovative financings and offerings, represents strategics, private equity firms, venture-backed businesses and entrepreneurs in buy- and sell-side M&A transactions, and counsels emerging as well as established and public companies in all aspects of their businesses, including intellectual property matters and regulatory approvals and compliance.

• • Intellectual Property practice of more than 130 professionals who represent clients in prosecution, strategy, business transactions, and litigation – more than 40 of whom have PhDs;
  • $80B+ in transactions since 2020, including public offerings, joint ventures, licensing and complex collaborations, mergers and acquisitions, divestitures, distribution deals, and private financings;
  • National reputation as go-to firm for high-stakes life sciences litigation, with an exemplary record in resolving disputes with collaboration/licensing partners and representing corporate officers and directors of life sciences companies in disputes; and
  • Regulatory and compliance advice spanning FDA strategy and interactions, clinical trials, fraud and abuse, compliance program development, HIPAA, marketing and advertising, drug pricing and reimbursement, supply and distribution agreements.